Gene Review:
SERPIND1 - serpin peptidase inhibitor, clade D...
Homo sapiens
Synonyms:
D22S673, HC-II, HC2, HCF2, HCII, ...
- Characteristics of the chemotactic activity of heparin cofactor II proteolysis products. Hoffman, M., Pratt, C.W., Corbin, L.W., Church, F.C. J. Leukoc. Biol. (1990)
- Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance. Cunningham, M.A., Bhakta, V., Sheffield, W.P. Thromb. Haemost. (2002)
- Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. Giri, T.K., Tollefsen, D.M. Blood (2006)
- Molecular and cellular basis for type I heparin cofactor II deficiency (heparin cofactor II Awaji). Kondo, S., Tokunaga, F., Kario, K., Matsuo, T., Koide, T. Blood (1996)
- Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Liu, L., Dewar, L., Song, Y., Kulczycky, M., Blajchman, M.A., Fenton, J.W., Andrew, M., Delorme, M., Ginsberg, J., Preissner, K.T. Thromb. Haemost. (1995)
- Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity. Reidl, L.S., Friedman, D.F., Goldman, J., Hardy, R.R., Jefferies, L.C., Silberstein, L.E. J. Immunol. (1991)
- Shape-shifting serpins--advantages of a mobile mechanism. Huntington, J.A. Trends Biochem. Sci. (2006)
- An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Andrew, M., Mitchell, L., Berry, L., Paes, B., Delorme, M., Ofosu, F., Burrows, R., Khambalia, B. J. Clin. Invest. (1992)
- Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4. Tollefsen, D.M., Pestka, C.A. J. Clin. Invest. (1985)
- Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. Hurst, R.E., Poon, M.C., Griffith, M.J. J. Clin. Invest. (1983)
- Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis. Corral, J., Aznar, J., Gonzalez-Conejero, R., Villa, P., Miñano, A., Vayá, A., Carrell, R.W., Huntington, J.A., Vicente, V. Circulation (2004)
- Decreased sensitivity to heparin in vitro in steroid-responsive nephrotic syndrome. Vermylen, C.G., Levin, M., Lanham, J.G., Hardisty, R.M., Barratt, T.M. Kidney Int. (1987)
- Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Bertina, R.M., van der Linden, I.K., Engesser, L., Muller, H.P., Brommer, E.J. Thromb. Haemost. (1987)
- Plasma heparin cofactor II in alcoholic liver disease. Andersson, T.R., Bell, H. J. Hepatol. (1988)
- Ability of the digene hybrid capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. Schachter, J., Hook, E.W., McCormack, W.M., Quinn, T.C., Chernesky, M., Chong, S., Girdner, J.I., Dixon, P.B., DeMeo, L., Williams, E., Cullen, A., Lorincz, A. J. Clin. Microbiol. (1999)
- Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity. Hoffman, M., Pratt, C.W., Brown, R.L., Church, F.C. Blood (1989)
- Leukocyte chemoattractant peptides from the serpin heparin cofactor II. Church, F.C., Pratt, C.W., Hoffman, M. J. Biol. Chem. (1991)
- Reformable intramolecular cross-linking of the N-terminal domain of heparin cofactor II: effects on enzyme inhibition. Brinkmeyer, S., Eckert, R., Ragg, H. Eur. J. Biochem. (2004)
- Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia. Kario, K., Matsuo, T., Kodama, K., Katayama, S., Kobayashi, H. Thromb. Res. (1992)
- Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex. Preissner, K.T., Sié, P. Thromb. Haemost. (1988)
- Isolation and characterization of a partial cDNA clone for heparin cofactor II1. Inhorn, R.C., Tollefsen, D.M. Biochem. Biophys. Res. Commun. (1986)
- Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. Shirk, R.A., Parthasarathy, N., San Antonio, J.D., Church, F.C., Wagner, W.D. J. Biol. Chem. (2000)
- Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. Petzelbauer, E., Seiffert, D., Beckmann, R., Pusch, B., Geiger, M., Binder, B.R. Thromb. Res. (1992)
- Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. Ehrlich, H.J., Keijer, J., Preissner, K.T., Gebbink, R.K., Pannekoek, H. Biochemistry (1991)
- Modulation of protein C inhibitor activity. Neese, L.L., Pratt, C.W., Church, F.C. Blood Coagul. Fibrinolysis (1994)
- The protease specificity of heparin cofactor II. Inhibition of thrombin generated during coagulation. Parker, K.A., Tollefsen, D.M. J. Biol. Chem. (1985)
- Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfate. Blinder, M.A., Andersson, T.R., Abildgaard, U., Tollefsen, D.M. J. Biol. Chem. (1989)
- Identification of two sites of sulfation of human heparin cofactor II. Hortin, G., Tollefsen, D.M., Strauss, A.W. J. Biol. Chem. (1986)
- Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. Herzog, R., Lutz, S., Blin, N., Marasa, J.C., Blinder, M.A., Tollefsen, D.M. Biochemistry (1991)